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the utilization of that services in Hungary. METHODS: Data were derived  
from the nationwide administrative dataset of the National Health Insurance 
Fund Administration (OEP), the only health care financing agency in Hungary. 
The utilization of home care (nursing) services was measured by the number  
of service provider, number of patients and the number of visits. We analzed  
the year 2011. RESULTS: The number of home care (nursing) service providers 
was 333. 80.8% of them was private for-profit, while 10.9% private non- 
profit organization. Altogether 51,000 patients was visited by home care 
providers (50 patients/10,000 population). The total annual number of visits  
was 1,190,000 (1193 visits/10,000 population). The average health insurance 
reimbursement of 1 visit was 2788 Hungarian Forint (HUF) (10.0 EUR), while  
the average reim-bursement of 1 patient was 65,345 HUF (234.0 EUR). 
CONCLUSIONS: We found that only 0.5 % of the Hungarian population 
underwent home care (nursing) services in 2011. Further development of  
home care services should be encouraged in order to reduce unnecessary 
hospital care.  
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OBJECTIVES: Prompt access to effective health care is a priority in the 
developmental agenda of Ghana yet only 20% of people who need health  
care have it. Several established health interventions such as home management 
of fever and community-based health planning and service (CHPS) are 
underway. However, evidence on the extent of prompt access to health care and 
the factors that influence these CHPS programme are woefully inadequate. The 
study sought to assess the role of geographical proximity and services 
characteristics on prompt access to health care in CHPS settings. METHODS:  
A descriptive cross sectional study was conducted in 2011 with 230 respondents 
within the CHPS zones of Bawjiase Sub-district, Central region of Ghana. Data 
were collected with structured questionnaire and analyzed using SPSS version  
16 software. Logistic regression was run to access the correlation of geographical 
proximity and service characteristics on prompt access to health care in CHPS 
settings at 95% confidence interval and 5% significance level. RESULTS: 
Knowledge about CHPS programme was almost universal 99%, nonetheless,  
87% of respondents accessed health care services after 24 hours, lived within a 
distance of 0.05-0.4 km from CHPS centers and 54% takes approximately 15-30 
minutes in reaching these settings, p<0.001. Factors associated with geographical 
proximity in prompt access to health care were good location, easy local 
accessibility (door step delivery) and distance less than 5Km. Majority 96%  
of the respondents presumed health care services availability, immediate 
attention on arrival (within 24hours) at the health care facilities and quality  
of health care were service characteristics that influenced prompt access  
to health care. CONCLUSIONS: The study concludes that geographical proximity 
and service characteristics influence prompt access to quality health  
care in rural CHPS setting. Rolling out CHPS initiative and further study  
on knowledge and beliefs on access in CHPS setting could inform 
implementation.  
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OBJECTIVES: Identify factors associated with referral patterns for warfarin 
therapy management to specialized care versus routine medical care after hip  
or knee replacement surgery. METHODS: We conducted a retrospective, 
observational study of patients who underwent total hip or total  
knee replacement surgery between the 2000 and 2009 and were referred to 
receive either specialized care at antithrombosis clinic or routine medical care  
at orthopedic clinic for post-surgical anticoagulation management.  
A multivariate logistic regression analysis was performed to identify factors that 
were associated with referral to antithrombosis clinic. RESULTS: A total of  
873 consecutive patients treated with warfarin were referred to the 
antithrombosis clinic (n=294) or orthopedic clinic (n=579). The majority  
of patients were females (68.3%) and the average age was 60±12.3 years. 
Hispanics (OR=4.24, 95% CI=2.38-7.57) compared to Caucasians, were more likely 
to be referred to antithrombosis clinic, as were Medicare patients (OR=2.03, 95% 
CI=1.27-3.25) compared to those with private insurance; divorced patients 
(OR=2.01, 95% CI=1.03-3.94) compared to those who were married; patients  
with >4 VTE risk factors (OR=3.06, 95% CI =1.16-8.10) compared to patients with  
1 VTE risk factor; smokers (OR=4.23, 95% CI=2.44-7.33) compared to non-smokers; 
and patients with extended length of post-surgery hospital stay (OR=2.27,  
95% CI=1.25-4.11). CONCLUSIONS: There were significant variations in referral 
patterns to specialized care versus routine care according to thrombosis  
risk profile and patient-related socio-demographic factors. An understanding  
of referral patterns to receive specialized care compared to routine medical  
care is important as these decisions can have an impact on the clinical 
outcomes, costs, and quality of care received by patients treated with 
anticoagulants.  
PHS90  
COMPARISON IN LENGTH OF HOSPITAL STAY RELATED TO THE DIAGNOSIS OF 
COPD PATIENTS BEFORE AND AFTER A PROGRAM OF PHARMACOTHERAPY 
MONITORING  
Estrada JI1, Sanchez L2, Serna JA1 
1CES University, Medellin, Colombia, 2Antioquia University, Medellin, Colombia  
OBJECTIVES: To compare numbers of admissions and days of hospitalization 
related to the diagnosis in a group of Chronic obstructive pulmonary disease 
(COPD), before and after their status as beneficiaries of a Pharmacotherapy 
Monitoring (PM). METHODS: Descriptive study, retrospective and comparison of 
results for a sample of patients (N=422) a year before and one year after receiving 
the intervention by PM; during this period they were recorded and classified as 
related or unrelated to the diagnosis COPD, all hospital admissions of patients, 
were quantified per stay days and a vector difference between the days before 
and after was built. RESULTS: Before the intervention by PM, 24% of patients had 
at least one hospital admission versus a 19% after; average length of stay before 
and after for both cases was 13 days with standard deviations of 11 and 13 
respectively. 18% of the patients reported a decrease in the length of stay days, 
66% remained the same and 15% reported an increase. The differences in the 
sociodemographic characteristics of patients with decreases and increases in the 
length of stay were those belonging to the average age (79 and 73 respectively) 
and schooling, where 22% of patients who had increases in the length of stay 
achieved at least high school degree compared with 34% of those who decreased. 
CONCLUSIONS: The comparison using descriptive statistics shows that the 
outcomes may be the result of intervention by PM. The significance of schooling 
outcomes lies in that the interventions made by PM, 72% are educating the 
patient/caregiver, which implies that a higher educational level would reflect 
greater response capacity. This work is a first step in a cohort comparison study.  
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OBJECTIVES: To examine medical resource utilization patterns prior to and post 
Alzheimer’s disease (AD) diagnosis in UK primary care. METHODS: Newly 
diagnosed patients with non-early onset AD between January 1, 2008 and 
December 31, 2010 were identified from the UK CPRD-GOLD database. The index 
date was defined as the first AD diagnosis. Eligible patients had a continuous 
record for the 3-year prior (index) period and 1-year post period, and were ≥65 
years of age. Controls were identified by matching to AD patients on year of 
birth, gender, region, and Charlson co-morbidity index with a 2:1 matching ratio. 
Medical resource utilization was calculated over the 4-year study period at 6-
monthly intervals. T-tests, chi-square tests, and Wilcoxon sum-rank tests 
(depending on the data type and distribution) were used comparing between AD 
and control. RESULTS: Cohorts of 3896 AD patients and 7792 controls were 
extracted. At index date, patients had a mean age (SD) of 79.8 (6.5) years and 65% 
were female. The mean primary care consultation rate per 6-month was higher 
in the AD cohort than the control cohort over the total study period (p<0.05) and 
showed a gradual increase in the controls over the 4 years (from 5-7 
consultations), while the AD cohort showed a clear increase in the 6-months 
prior to the index (10 consultations) and stayed at this high rate over the 1-year 
post-diagnosis period. The proportion of patients with a secondary care referral 
was higher within the AD cohort than the control cohort (37% vs. 25% over the 4-
year period, p<0.05), with the difference peaking in the 6-month prior to AD 
diagnosis (17% vs. 5%, p<0.05). CONCLUSIONS: A clear increase in primary care 
consultations in the 6-month period prior to AD diagnosis and its continuation in 
the year post-diagnosis suggest AD imposes a substantial burden on UK primary 
care.  
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OBJECTIVES: The objective of this study was to determine the inpatient burden 
among women diagnosed with vulvar cancer using the 2009 Health care Utili-
zation Project Nationwide Inpatient Sample (HCUP-NIS) database. METHODS: A 
retrospective, cross-sectional study design was used. Inpatient burden among 
women with vulvar cancer (cases) was compared to those without vulvar cancer 
(controls). Further, factors predicting average length of stay (LOS), total charges, 
and mortality among cases were determined. Analyses (PROC SURVEY 
procedures) were performed using SAS ver.9.2. RESULTS: In 2009, there were 
6,318 hospitalizations among women with vulvar cancer in the US. The overall 
rate of vulvar cancer-related hospitalizations was 31.89/100,000. The average 
total hospital charges, comorbidity scores, and number of procedures recorded 
were higher among cases versus controls. Average LOS was significantly longer 
among cases discharged to other health facilities as compared to cases that were 
routinely discharged. Greater number of diagnoses and procedures recorded 
were associated with longer LOS. An increase in the number of procedures 
recorded and longer LOS were associated with higher total charges. Inpatient 
mortality was higher among women of lower income and those admitted to rural 
hospitals. Mortality among women with vulvar cancer also increased with LOS 
and number of diagnoses on record. CONCLUSIONS: To the best of our 
knowledge, this is the first study to use a nationally representative database to 
provide information related to inpatient burden among women with vulvar 
cancer. Policy makers could use study results when making resource allocation 
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decisions, with the aim of improving inpatient outcomes among women with 
vulvar cancer.  
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OBJECTIVES: To describe the pattern of care, costs, and outcomes of chest pain 
patients at two years after an initial ER visit using large longitudinal claim 
database. METHODS: This was a retrospective cross-sectional study using 
BlueCross BlueShield of Texas claims data of patients with unspecific chest pain 
(from 2008 to 2011). Only patients who have had three years of continuous 
enrollment with six months prior to their initial visits to the ER and at least two 
years of follow-up after the ER visit were included. Patients were categorized into 
four groups; group1 included patients who were sent home after their ER visit, 
group2 included patients who were admitted into observation units, group3 
included patients who were admitted into inpatient care and group4 included 
patients who were transferred into observation units and then inpatient care. 
The measured outcomes included myocardial infarction (MI), invasive cardiac 
procedures and associated costs of circulatory diseases subsequent to the 
emergency room visits up to two years of follow-up. RESULTS: A total of 172,627 
met the inclusion criteria. Of those, 23.30% enrollees (40,219) had ER visits. 
Group1 included 28.1% of the total patients, group2 included 66.77%, group3 
included 1.13% and group4 included 4.04%. The highest percentage of PTCA and 
CABG procedures were observed in group3 (13%, 11.7%) followed by group4 (7.9%, 
1.7%), group1 (4.7%, 1.4%) and group2 (4.2%, 0.99%). The highest percentage of MI 
were observed in group3 (21.9%) followed by group4 (5.7%), group2 (4, 4.1%) and 
group1(3.3%). Group3 had also the highest cost associated with circulatory 
diseases with a median of ($12,084) followed by group4 ($1,496), group1($1,154) 
and group2 ($915). CONCLUSIONS: Based on the preliminary descriptive 
statistics, patients admitted to observation units, in our population, had  
the lowest percentage of cardiac invasive procedures and circulatory  
diseases associated costs at two years of follow-up after an initial ER visit with 
chest pain.  
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OBJECTIVES: To assess the effects of adverse drug events (ADEs) as the reason 
for admission on hospital length of stay (LOS) and hospitalization costs in  
US hospitals. METHODS: The study used the Nationwide Inpatient Sample of  
the Healthcare Cost and Utilization Project for 2003-2009. ADEs were defined as 
drug poisoning due to inappropriate medication uses or errors and adverse 
effects from drugs administered. A case-control matching method was used to 
determine LOS and hospitalization costs attributable to ADEs. For each case 
patient, one control patient was matched based on sex, age(±5 years), race, exact 
diagnosis, same hospital and same calendar year of discharge. LOS and 
hospitalization costs attributable to ADEs were estimated using the recycled 
prediction method. This method predicted outcomes for patients with ADEs  
by calculating outcomes using estimated coefficients from all sample  
using generalized linear model after adjusting for the study variables. Then,  
LOS and hospitalization costs attributable to ADEs were defined as  
the differences between the predicted outcomes assuming the patients  
with ADEs as having ADEs and the predicted outcomes assuming the patients 
with ADEs not having ADEs. All costs were converted to 2011 US dollars using 
consumer’s price indices and calculated per-discharge. RESULTS: A total of  
6076 patients with ADEs were matched with control patients. The matched 
control patients had a mean LOS of 4.50 days versus 4.85 (p<0.05) for patients 
with ADEs. The average hospitalization cost for control patients was  
$7648 compared to $7785 for patients with ADEs. The LOS attributable to ADEs 
was 0.36 days per admission and the mean hos-pitalization cost attributable to 
ADEs was $550 per admission. CONCLUSIONS: The incidence of ADE 
significantly increases LOS and hospitalization costs. To reduce these outcomes, 
it is necessary that a systematic approach to improve drug use process is 
undertaken including the monitoring of ADEs as an important outcome of 
pharmacotherapy.  
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OBJECTIVES: Incremental health care resource utilization associated with 
autosomal dominant polycystic kidney disease (PKD) was estimated. METHODS: 
Study data were from a large administrative claims and enrollment database. 
Individuals 18 y/o or older, enrolled in tracked health plans for 12 months from 
April 1, 2011 through March 31, 2012, and with an ICD-9-CM diagnosis code for 
“polycystic kidney, autosomal dominant” (753.13) or for “polycystic kidney, 
unspecified type (753.12) were identified as having autosomal dominant PKD. A 
comparison group of individuals who met all inclusion criteria except were not 
classified as having autosomal dominant PKD, autosomal recessive PKD, cystic 
kidney disease, chronic kidney disease stage 3 or higher, nephrotic syndrome, 
diabetic kidney disease or kidney stones associated with cystic kidney disease 
was matched one-to-one with individuals with PKD on age and gender. Zero-
inflated negative binomial models estimated associations between PKD and hos-
pitalizations, hospital days, nursing home stays, nursing home days, inpatient 
psychiatric hospital stays, inpatient psychiatric hospital days, emergency room 
visits and outpatient visits, after adjusting for age, gender, Charlson co-
morbidity index, cardiovascular disease, diabetes and geographical region. 
RESULTS: A total of 3844 individuals with PKD, satisfied selection criteria and 
were matched with 3844 individuals without PKD. The sample was 53% female 
and 55% were between 45 to 64 years old. The PKD group was more likely to have 
cardiovascular disease (25.6% vs. 13.3%, p<0.001), diabetes (14.1% vs. 10.0%, 
p<0.001) and Charlson comorbidity index scores greater than zero (55.8% versus 
37.5%, p<0.001). Autosomal dominant PKD was associated with marginally more, 
mean (standard error), hospitalizations 0.09 (0.01), p<0.001, hospital days 0.68 
(0.08), p<0.001, emergency room encounters 0.29 (0.06), p<0.001 and outpatient 
encounters 6.9 (0.28), p<0.001. CONCLUSIONS: Autosomal dominant PKD was 
associated with incrementally greater health care resource utilization especially 
for outpatient encounters.  
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OBJECTIVES: To investigate the prevalence of cancer comorbidity in individuals 
with diabetes, and its association with health care use and expenditures. 
METHODS: Our study was conducted with a quasi-experimental design ap-
proach. Subjects included patients who reported having diabetes from the 2010 
Medical Expenditure Panel Survey (MEPS). The propensity scores technique was 
utilized to match patients with cancer versus without cancer to reduce selection 
bias in observable risk factors such as age, sex, race/ethnicity, physical activity, 
smoking and body mass index. Further, a series of weighted inferential statistics 
were used to test the effect of cancer comorbidity on the variables associated 
with health care use and expenditures. All analyses were accomplished by 
taking into consideration with MEPS sample clustering, stratification, and weight 
adjustments using SAS 9.22 analytical software. RESULTS: There were an 
estimated 21.03 million non-institutionalized adults who reported having 
diabetes in the US in 2010, of which, 3.89 million (18.5%) had cancer comorbidity. 
Individuals with diabetes were twice as likely as a comparable sample from the 
general US population to be diagnosed with cancer (odds ratio 2.1, 95% CI 1.9–
2.49). Variables associated with health care use and expenditures (total office-
based use and expenditures, outpatient department use and expenditures, 
emergency facility use and expenditures, prescription medication use and 
expenditures, etc.) for individuals with cancer were significantly higher than 
those without cancer (p< 0.0001). CONCLUSIONS: Our study findings indicate the 
cancer individuals with diabetes are associated with increased health care use 
and expenditures. The major implementation may be benefit from early 
identifying selected diabetes patients because they seem to be at higher risk for 
cancer.  
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